Drugnews|藥時事

iXensor

安盛生科股份有限公司

6734 · Emerging Stock Board

iXensor focuses on home / point-of-care testing and digital health, as of 2026-11-01.

Pipeline and products

No publicly disclosed new-drug pipeline.

Key events

Related Drugnews articles

No related articles in this language.